In order to understand the possible effect of CBZ on SMARCA4 expression in KRAS-mut and KRAS-wt tumors, CRC cell lines were treated with 50uM of CBZ for 6 or 24 h. The gene discussed is KRAS; the disease is colorectal carcinoma.